apotex

This company was established in 1974 and is the largest Canadian-owned pharmaceutical company.

The company's own business is developing and manufacturing general pharmaceuticals, the success of Apotex has made it possible to diversify into a number of other health-related fields. The Apotex Pharmaceutical Group of Companies also researches, develops, manufactures and distributes fine chemicals, non-prescription and private label medicines, and disposable plastics for medical use.

Their nowadays aim is in the fields of hematology, neurodegenerative diseases and psoriasis. In addition, Apotex's first innovative drug, Ferriprox™, is approved in over 50 countries.

Moreover, their newest field of research, psoriasis, saw ApoPharma initiate clinical trials in 2008 to evaluate the safety and efficacy of a novel dipeptide.